Timber Pharmaceuticals Inc (TMBR)

NYSE
1.5300
-0.0500(-3.16%)
After Hours
1.5000
-0.0300(-1.9608%)
- Real-time Data
  • Volume:
    64,993
  • Day's Range:
    1.5000 - 1.5800
  • 52 wk Range:
    1.3200 - 22.7450

TMBR Overview

Prev. Close
1.58
Day's Range
1.5-1.58
Revenue
540K
Open
1.58
52 wk Range
1.32-22.745
EPS
-12.96
Volume
64,993
Market Cap
4.55M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
162,642
P/E Ratio
-
Beta
-
1-Year Change
-92.32%
Shares Outstanding
2,971,439
Next Earnings Date
Mar 21, 2023
What is your sentiment on Timber Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Timber Pharmaceuticals Inc News

Timber Pharmaceuticals Inc Company Profile

Timber Pharmaceuticals Inc Company Profile

Employees
5

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company’s lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in the development of TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. In addition, the company engages in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. It has license agreement with AFT Pharmaceuticals Limited. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Read More

Analyst Price Target

Average75.0000 (+4801.96% Upside)
High75
Low75
Price1.53
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellBuySellNeutral
Technical IndicatorsSellStrong SellNeutralStrong SellSell
SummarySellStrong SellNeutralStrong SellNeutral
  • moving up buy and hold
    0
    • Exploding
      0
      • This is going to go absolutely nuts! Let's burn the Shorts!
        0
        • in at 0.54 ... that offering will close the gap up
          0
          • Bought at 1,73
            1
            • Sold at 2,00
              0
          • Why its falling any idea?
            1
            • some guy did voodoo
              0
          • I see technicak level around 4.40. Any ideas on fundamental strenght?
            2
            • Target 3.0
              2
              • Its over again. Target 6$ from 3 now
                2
            • I can see it at 2.40 soon
              0
              • Good call
                0
              • 2.4
                0
            • Easy 6 dollar stock no questions asked
              2